Thema: US48576U2050
KPTI, US48576U2050
chart-1905225_1920.jpg - Foto: THN
Karyopharm stock faces November 2 earnings test
Karyopharm stock heads into an earnings release with analysts expecting lower revenue than a year earlier. The report may clarify the business trajectory.
ad-hoc-news.de, heute 18:48 Uhr
KPTI, US48576U2050
Karyopharm schedules November 2 results for Karyopharm stock ...
Q3 revenue consensus is USD 33.54 million versus USD 33.43 million in Q2. Karyopharm stock costs EUR 0.41 on October 27, 2026 at 10:52 p.m. CEST.
ad-hoc-news.de, 27.10.26 22:54 Uhr
KPTI, US48576U2050
Karyopharm Therapeutics stock sits 95.48 percent below target ...
Karyopharm's next report is estimated for November 2, 2026 before market opens. Karyopharm Therapeutics stock costs EUR 0.46 on October 24, 2026.
ad-hoc-news.de, 24.10.26 21:40 Uhr
KPTI, US48576U2050
Karyopharm stock: November 2 is the estimated results date ...
Second-quarter revenue was USD 33.43 million versus USD 37.90 million. Karyopharm stock costs EUR 0.51 on October 22, 2026 at 10:48 p.m. CEST.
ad-hoc-news.de, 22.10.26 22:50 Uhr
KPTI, US48576U2050
Investing.com lists USD 7.25 target for Karyopharm stock ...
Second-quarter revenue was USD 33.43 million versus USD 37.90 million on August 13, 2026. Karyopharm stock costs EUR 0.32 on October 20, 2026 at 7:53 p.m. CEST.
ad-hoc-news.de, 20.10.26 20:00 Uhr
KPTI, US48576U2050
Karyopharm stock approaches November 2 earnings with USD ...
Second-quarter revenue was USD 33.43 million versus USD 37.90 million. Karyopharm stock stood at USD 0.39 on October 16, 2026, up 11.20 percent.
ad-hoc-news.de, 17.10.26 20:46 Uhr
KPTI, US48576U2050
Six analysts give Karyopharm stock a USD 11.50 consensus ...
KPTI guides USD 130.00 million to USD 150.00 million in 2026 revenue. Karyopharm stock costs EUR 0.29 on October 15, 2026 at 8:35 p.m. CEST.
ad-hoc-news.de, 15.10.26 20:42 Uhr
